Comgest Growth Europe USD I AccRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31-10-2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | 11,3 | 35,4 | -20,2 | 23,8 | 1,6 | |
+/-Cat | 2,8 | 10,8 | 0,3 | 7,6 | -1,7 | |
+/-Idx | - | - | - | 7,6 | -5,7 | |
Categorie: Aandelen Europa Large-Cap Groei | ||||||
Categorie Benchmark: Morningstar Dev Europe Grt ... |
Kerngegevens | ||
Koers 20-11-2024 | USD 47,58 | |
Rendement 1 Dag | 0,00% | |
Morningstar Categorie™ | Aandelen Europa Large-Cap Groei | |
Vestigingsland | Ierland | |
ISIN | IE00BJMZ1027 | |
Grootte Fonds (Mil) 19-11-2024 | EUR 5510,91 | |
Grootte Fondsklasse (Mil) 19-11-2024 | USD 61,57 | |
Aankoopkosten (Max) | - | |
Lopende Kosten Factor 04-06-2024 | 1,06% |
Morningstar Research |
Analyst Report | 11-07-2024 Mathieu Caquineau, Director Morningstar, Inc |
Comgest Growth Europe’s strong and cohesive team and its time-tested growth strategy make it an outstanding choice for investors. The strategy earns People and Process pillar ratings of High. As a result, the Ireland-domiciled fund’s I and clean... | |
Klik hier voor het analistenrapport |
Pijlers Morningstar | |
---|---|
Team | 25 |
Fondshuis | 24 |
Proces | 25 |
Rendement | |
Kosten |
Beleggingsdoelstelling: Comgest Growth Europe USD I Acc |
The investment objective of the Comgest Growth Europe fund is to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies based or operating in Europe. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Franz Weis 01-11-2009 | ||
Eva Fornadi 30-08-2024 | ||
Click here to see others | ||
Oprichtingsdatum 19-05-2014 |
Advertentie |
Categorie Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI Europe NR EUR | Morningstar Dev Europe Grt TME NR EUR |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? Comgest Growth Europe USD I Acc | 31-10-2024 |
|
|
Top 5 posities | Sector | % |
Novo Nordisk AS Class B | Gezondheidszorg | 7,28 |
ASML Holding NV | Technologie | 6,44 |
Essilorluxottica | Gezondheidszorg | 5,32 |
Schneider Electric SE | Industrie | 4,87 |
Alcon Inc | Gezondheidszorg | 4,33 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
Comgest Growth Europe USD I Acc |